Top Markets
Coin of the day
Lexeo Therapeutics, Inc. Common Stock Lexeo Therapeutics, Inc. Common Stock

Lexeo Therapeutics, Inc. Common Stock

LXEO
Classificação em ações #15118
Lexeo Therapeutics, Inc. is a genetic medicine firm currently in the clinical... Lexeo Therapeutics, Inc. is a genetic medicine firm currently in the clinical development phase, dedicated to addressing both inherited and acquired medical conditions. Its robust pipeline features several gene therapy candidates. These include LX2006, an AAVrh10-based therapy aimed at treating cardiomyopathy linked to Friedreich's ataxia (FA); LX2020, another AAVrh10-based candidate targeting arrhythmogenic cardiomyopathy; LX2021, designed for DSP cardiomyopathy; and LX2022, which focuses on hypertrophic cardiomyopathy (HCM) stemming from TNNI3 mutations. Furthermore, Lexeo is advancing LX1001, an AAVrh10-based gene therapy, alongside LX1020 and LX1021, all intended for individuals homozygous for APOE4. Additionally, LX1004 is under development to treat CLN2 Batten disease. Established in 2017, the company's headquarters are located in New York, New York.
Preço da ação
$4.74
Última sincronização: 2026-08-31
Valor de mercado
$372.19M
Variação (1 dia)
-2.47%
Variação (1 ano)
-1.04%
País
US
Negociar Lexeo Therapeutics, Inc. Common Stock (LXEO)

Categoria

Preço LXEO com a capitalização de mercado de B
Lexeo Therapeutics, Inc. Common Stock Lexeo Therapeutics, Inc. Common Stock
LXEO
$4.74
Capitalização de mercado de Lexeo Therapeutics, Inc. Common Stock(LXEO)
Valor de mercado: $372.19M
Em September 2026, Lexeo Therapeutics, Inc. Common Stock tem uma capitalização de mercado de $372.19M. Isso faz com que Lexeo Therapeutics, Inc. Common Stock seja a 15118th empresa mais valiosa do mundo em termos de capitalização de mercado, de acordo com os nossos dados. A capitalização de mercado, também chamada de market cap, é o valor total de mercado das ações em circulação de uma empresa de capital aberto e é amplamente utilizada para medir o valor de uma empresa.
Histórico de capitalização de mercado de Lexeo Therapeutics, Inc. Common Stock de 2023 a 2026
LXEO comparado com o topo de 5 mais populares stocks
Preço para LXEO Ativo B Capitalização de mercado de B Resultados
Lexeo Therapeutics, Inc. Common Stock Lexeo Therapeutics, Inc. Common Stock
$67,838.67 $372.19M
$5.327T +1,431,095.66%
Lexeo Therapeutics, Inc. Common Stock Lexeo Therapeutics, Inc. Common Stock
$59,154.10 $372.19M
$4.645T +1,247,876.74%
Lexeo Therapeutics, Inc. Common Stock Lexeo Therapeutics, Inc. Common Stock
$51,836.16 $372.19M
$4.070T +1,093,489.98%
Lexeo Therapeutics, Inc. Common Stock Lexeo Therapeutics, Inc. Common Stock
$48,197.93 $372.19M
$3.785T +1,016,733.97%
Lexeo Therapeutics, Inc. Common Stock Lexeo Therapeutics, Inc. Common Stock
$35,533.17 $372.19M
$2.790T +749,545.01%